Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons

Nischal Ranganath, John C. O'Horo, Douglas W. Challener, Sidna M. Tulledge-Scheitel, Marsha L. Pike, Michael O'Brien, Raymund R. Razonable, Aditya Shah

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons'. Together they form a unique fingerprint.

Medicine & Life Sciences